WebSyncona Ltd (Syncona) is a closed-ended investment company. Its services include founding, building, and funding companies. The company makes investments in life sciences companies including gene therapy, cell therapy, biologics, and small molecule fields. Syncona’s portfolio companies include Freeline Therapeutics, SwanBio … WebIn 2024 Syncona co-led the company’s $110 million Series A financing round, committing $19 million alongside EcoR1 Capital, Jeito Capital, Polaris Partners, Pontifax, Vida …
Syncona Ltd Company Profile - Overview - GlobalData
WebOct 1, 2024 · Syncona, is a leading FTSE 250 healthcare company focused on creating, building and scaling a portfolio of global leaders in life science. Our vision is to build a … WebProud to be an Ambassador for GroceryAid🌈, raising awareness and supporting our industry's charity! #fmcg #groceryaid. Liked by Sarah … playlist live 2023
John Bradshaw - Chief Financial Officer @ Syncona Partners LLP ...
WebMar 30, 2024 · 59. 2024. Gian Reverberi. Non-Executive Independent Director. 52.00k GBP. --. 2024. Officers and Directors data as of Mar 14 2024. View all 22 directors & officers. WebSyncona Partners LLP has made 3 diversity investments. Their most recent diversity investment was on May 18, 2024, when SwanBio Therapeutics raised $56M. Syncona Partners LLP has had 8 exits. Syncona Partners LLP 's most notable exits include Neogene Therapeutics , Autolus , and Freeline. Syncona Partners LLP has acquired AGTC on Oct … WebChris is the Chief Investment Officer of Syncona Investment Management Ltd. He is currently Chairman at five Syncona companies: NightStar Therapeutics (NASDAQ:NITE), Freeline Therapeutics, Gyroscope Therapeutics, Swan Therapeutics and Orbit Biomedical. He has been instrumental in their foundation and development including the acquisition of … playlist live 2022